Nitric oxide-mediated inhibition of Hdm2-p53 binding
Biochemistry & Molecular Pharmacology
Graduate School of Biomedical Sciences; Department of Biochemistry and Molecular Pharmacology; Department of Cell Biology
Life Sciences | Medicine and Health Sciences
It has become increasingly evident that nitric oxide exerts its effects, in part, by S-nitrosylation of cysteine residues. We tested in vitro whether nitric oxide may indirectly control p53 by S-nitrosylation and inactivation of the p53 negative regulator, Hdm2. Treatment of Hdm2 with a nitric oxide donor inhibits Hdm2-p53 binding, a critical step in Hdm2 regulation of p53. The presence of excess amounts of cysteine or dithiothreitol blocks this inhibition of binding. Moreover, nitric oxide inhibition of Hdm2-p53 binding was found to be reversible. Sulfhydryl sensitivity and reversibility are consistent with nitrosylation. Finally, we have identified a critical cysteine residue that nitric oxide modifies to disrupt Hdm2-p53 binding. This cysteine is proximal to the Hdm2-p53 binding interface and is conserved across species from zebrafish to humans. Mutation of this residue from a cysteine to an alanine does not interfere with binding but rather eliminates the sensitivity of Hdm2 to nitric oxide inactivation.
DOI of Published Version
Biochemistry. 2002 Nov 19;41(46):13570-4.
Schonhoff CM, Daou M, Jones SN, Schiffer CA, Ross AH. (2002). Nitric oxide-mediated inhibition of Hdm2-p53 binding. GSBS Student Publications. https://doi.org/10.1021/bi026262q. Retrieved from https://escholarship.umassmed.edu/gsbs_sp/1081